BuSpar

    <p class=default>
      <span style="color: #000000; font-size: 8pt; font-family: Arial">
        BMS stopped from filing extension patents for BuSpar; judge sees it as anticompetitive. 
      </span>
    </p>
    <p class=default>
      <span style="color: #000000; font-size: 8pt; font-family: Arial">
        
      </span>
    </p>
    <p class=default>
      <span style="color: #000000; font-size: 8pt; font-family: Arial">
        Bristol-Myers's secondary patent covers a chemical substance made in the body when 
        patients take BuSpar. 
      </span>
    </p>
    <p class=default>
      <span style="color: #000000; font-size: 8pt; font-family: Arial">
        
      </span>
    </p>